Publication - Advice and guidance
Fertility preservation provision in the NHS in Scotland: guidance
Scottish Government and NHS Scotland fertility preservation guidance provides recommendations and guidance for clinicians on which patient groups should be considered for fertility preservation treatment and individual eligibility criteria.
Annex B
| Cancer site/type (ICD-10) | Sex | 15-19 | 20-24 | 25-29 | 30-34 | 35-39 | Total | |
|---|---|---|---|---|---|---|---|---|
| All Cancer Types | M | 23 | 55 | 74 | 115 | 152 | 419 | |
| - | F | 24 | 47 | 110 | 232 | 353 | 766 | |
| All Malignant Neoplasms | M | 5 | 4 | 5 | 4 | 1 | 19 | |
| (Bone and connective) | F | 3 | 4 | 4 | 4 | 3 | 18 | |
| Breast (C50) | F | - | 1 | 22 | 64 | 144 | 231 | |
| Cervix uteri (C53) | F | - | 1 | 11 | 39 | 53 | 104 | |
| Ovary (C56) | F | 2 | 7 | 13 | 10 | 13 | 45 | |
| Testis (C62) | M | - | 12 | 25 | 38 | 34 | 109 | |
| Hodgkin lymphoma (C81) | M | 7 | 8 | 7 | 7 | 13 | 42 | |
| - | F | 7 | 8 | 8 | 10 | 4 | 37 | |
| Non Hodgkin | M | - | 6 | 4 | 4 | 10 | 24 | |
| Lymphoma (C82 – 86) | F | 1 | 2 | 1 | 5 | 5 | 14 | |
| Acute Lymphoblastic | M | 4 | 1 | - | 2 | - | 7 | |
| Leukaemia (C91) | F | 3 | - | 1 | 1 | 1 | 6 | |
| Acute Myeloblastic | M | - | - | - | - | - | 0 | |
| Leukaemia (C92) | F | - | 1 | 1 | - | 1 | 3 | |
| Colon (C18) | M | 1 | 1 | 5 | 11 | 14 | 32 | |
| F | - | 2 | 1 | 13 | 19 | 35 | ||
| Brain (C71) | M | 2 | 4 | 5 | 6 | 8 | 25 | |
| - | F | - | - | 2 | 8 | 9 | 19 | |
Subtotals
M
These cancers (exc. all cancer types), these ages total 258
F
These cancers (exc. all cancer types), these ages total 512
Data extracted by Anthea Taylor from statistics published by Public Health Scotland, 26 November 2024.
Many people will have had a child at the time of diagnosis and thus not be eligible for NHS fertility preservation.
Contact
Email: anthea.taylor@gov.scot